Sentry Investment Management LLC Has $92,000 Holdings in Cardinal Health, Inc. (NYSE:CAH)

Sentry Investment Management LLC decreased its position in Cardinal Health, Inc. (NYSE:CAH) by 23.0% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 734 shares of the company’s stock after selling 219 shares during the quarter. Sentry Investment Management LLC’s holdings in Cardinal Health were worth $92,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in CAH. DAVENPORT & Co LLC lifted its stake in shares of Cardinal Health by 3.3% in the 4th quarter. DAVENPORT & Co LLC now owns 5,740 shares of the company’s stock valued at $679,000 after purchasing an additional 182 shares during the last quarter. Greenleaf Trust boosted its stake in shares of Cardinal Health by 15.4% during the 4th quarter. Greenleaf Trust now owns 5,201 shares of the company’s stock worth $615,000 after acquiring an additional 694 shares in the last quarter. U.S. Capital Wealth Advisors LLC increased its holdings in shares of Cardinal Health by 12.2% during the 4th quarter. U.S. Capital Wealth Advisors LLC now owns 3,738 shares of the company’s stock valued at $442,000 after acquiring an additional 406 shares during the last quarter. E. Ohman J or Asset Management AB raised its stake in shares of Cardinal Health by 15.0% in the 4th quarter. E. Ohman J or Asset Management AB now owns 11,500 shares of the company’s stock valued at $1,360,000 after acquiring an additional 1,500 shares in the last quarter. Finally, Avitas Wealth Management LLC acquired a new stake in Cardinal Health in the 4th quarter worth approximately $1,466,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Performance

NYSE:CAH opened at $154.19 on Thursday. The company has a 50-day moving average of $142.85 and a 200-day moving average of $130.95. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $157.82. The company has a market capitalization of $36.80 billion, a price-to-earnings ratio of 28.77, a PEG ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, topping analysts’ consensus estimates of $2.15 by $0.20. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The firm had revenue of $54.88 billion during the quarter, compared to analysts’ expectations of $55.33 billion. During the same quarter last year, the company earned $2.08 earnings per share. The company’s revenue for the quarter was up .0% compared to the same quarter last year. Sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be paid a dividend of $0.5107 per share. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.04 annualized dividend and a yield of 1.32%. The ex-dividend date of this dividend is Tuesday, July 1st. Cardinal Health’s dividend payout ratio is currently 31.83%.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on CAH. Mizuho lifted their price target on shares of Cardinal Health from $142.00 to $150.00 and gave the company an “outperform” rating in a research report on Monday, March 31st. Bank of America boosted their target price on shares of Cardinal Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research report on Friday, April 11th. Jefferies Financial Group raised Cardinal Health from a “hold” rating to a “buy” rating and raised their price target for the company from $140.00 to $150.00 in a research report on Wednesday, February 5th. Wells Fargo & Company upgraded Cardinal Health from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $136.00 to $179.00 in a research note on Tuesday. Finally, Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Monday, May 5th. Three analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $149.50.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.